Benjamin Davis

1.2k citations
9 papers · 923 · 2 hit papers · h-index 6

Impact in

  • Virology top 5%
    • Rabies epidemiology and control
  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • interferon and immune responses
    • Immune responses and vaccinations

Papers in

    • SARS-CoV-2 and COVID-19 Research 2
    • Clostridium difficile and Clostridium perfringens research 1
    • Viral Infections and Vectors 1
    • Viral Infections and Outbreaks Research 1
    • Rabies epidemiology and control 2

Benjamin Davis

9 papers receiving 894 citations

Benjamin Davis's Hit Papers

A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection 2024 · 62 citations
620+1+3Years since publication100200300400500

Peers

Benjamin Davis
Comparison fields: 5 of 68
  • Virology 130
  • Immunology 259
  • Infectious Diseases 203
  • Molecular Biology 312
  • Pharmaceutical Science 21
Replace Danushka K. Wijesundara with:
Danushka K. Wijesundara Australia
Zekun Mu United States
Veronica M. Holmes United States
Rebecca J. Nusbaum United States
Erik S. Van Dis United States
Jenna L Lobby United States
Pierre Rosenbaum France
Chutamath Sittplangkoon Thailand
Kaustuv Banerjee United States
Kristen A. Rodrigues United States
Benjamin Davis relative to Danushka K. Wijesundara Australia Danushka K. Wijesundara's profile →
Citations per field
00.5×2×3×
Danushka K. Wijesundara · 1×
Citations per year

Countries citing papers authored by Benjamin Davis

Since Specialization
Citations

This map shows the geographic impact of Benjamin Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Davis more than expected).

Fields of papers citing papers by Benjamin Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Davis. The network helps show where Benjamin Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Davis Line = papers co-authored together Benjamin Davis links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Hit paper breakdown →
2021592
2 2015133
3 201487
4
A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection
Hit paper breakdown →
202462
5 201736
6 20259
7 20222
8 20251
9 20261

About Benjamin Davis

Benjamin Davis is a scholar working on Infectious Diseases, Virology, Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 923 indexed citations. Recurring topics across this work include Rabies epidemiology and control (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), RNA Interference and Gene Delivery (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Viral Infections and Vectors (1 paper), Viral Infections and Outbreaks Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Virology (130 citations), Immunology (259 citations), Infectious Diseases (203 citations), Molecular Biology (312 citations) and Pharmaceutical Science (21 citations). Benjamin Davis has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Matthias J. Schnell, Glenn F. Rall, Jianhong Lu, Gordon T. Ruthel, Yuliang Liu, Allen B. Reitz, Jay E. Wrobel, Mark A. Olson, Bruce D. Freedman and Ziying Han. Their work appears in journals such as Journal of Virology, Molecular Genetics and Metabolism, Nature Communications, Annual Review of Virology and npj Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact